X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
electricity (37) 37
index medicus (37) 37
animals (31) 31
chemistry (29) 29
basic electric elements (28) 28
metallurgy (28) 28
performing operations (27) 27
transporting (27) 27
female (23) 23
male (23) 23
physics (23) 23
oncology (22) 22
hematology (21) 21
chronic myeloid-leukemia (19) 19
mice (19) 19
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (17) 17
electric solid state devices not otherwise provided for (16) 16
molecular sequence data (16) 16
semiconductor devices (16) 16
blasting (15) 15
heating (15) 15
lighting (15) 15
mechanical engineering (15) 15
weapons (15) 15
biochemistry & molecular biology (13) 13
cell line, tumor (13) 13
research (13) 13
amino acid sequence (12) 12
chronic myelogenous leukemia (12) 12
chronic myeloid leukemia (12) 12
fixed constructions (12) 12
fusion proteins, bcr-abl - genetics (12) 12
imatinib (12) 12
adult (11) 11
apoptosis (11) 11
cell line (11) 11
human necessities (11) 11
microbiology (11) 11
phosphorylation (11) 11
proteins (11) 11
clostridium perfringens (10) 10
engineering elements and units (10) 10
general measures for producing and maintaining effectivefunctioning of machines or installations (10) 10
middle aged (10) 10
mutation (10) 10
thermal insulation in general (10) 10
vehicles in general (10) 10
antineoplastic agents - pharmacology (9) 9
cancer (9) 9
gene expression (9) 9
antineoplastic agents - therapeutic use (8) 8
calculating (8) 8
chemical surface treatment (8) 8
cloning (8) 8
clostridium perfringens - genetics (8) 8
coating by vacuum evaporation, by sputtering, by ion implantationor by chemical vapour deposition, in general (8) 8
coating by vacuum evaporation, by sputtering, by ionimplantation or by chemical vapour deposition, in general (8) 8
coating material with metallic material (8) 8
coating metallic material (8) 8
computing (8) 8
counting (8) 8
diffusion treatment of metallic material (8) 8
electric digital data processing (8) 8
escherichia-coli (8) 8
fusion proteins, bcr-abl - metabolism (8) 8
hemic and lymphatic diseases (8) 8
imatinib mesylate (8) 8
inhibiting corrosion of metallic material or incrustation ingeneral (8) 8
leukemia (8) 8
leukemia, myelogenous, chronic, bcr-abl positive - genetics (8) 8
measuring (8) 8
mice, nude (8) 8
organic chemistry (8) 8
protein kinase inhibitors - pharmacology (8) 8
removable external protective coverings specially adapted forvehicles (8) 8
surface treatment of metallic material by diffusion into thesurface, by chemical conversion or substitution (8) 8
testing (8) 8
windows, windscreens, non-fixed roofs, doors, or similardevices for vehicles (8) 8
aged (7) 7
apoptosis - drug effects (7) 7
article (7) 7
base sequence (7) 7
biophysics (7) 7
cell proliferation - drug effects (7) 7
cloning, molecular (7) 7
compounds thereof (7) 7
general tagging of cross-sectional technologies spanning over several sections of the ipc (7) 7
general tagging of new technological developments (7) 7
hygiene (7) 7
inorganic chemistry (7) 7
medical or veterinary science (7) 7
medicine, research & experimental (7) 7
non-metallic elements (7) 7
nucleotide-sequence (7) 7
piperazines - pharmacology (7) 7
preparations for medical, dental, or toilet purposes (7) 7
protein kinase inhibitors - therapeutic use (7) 7
protein-tyrosine kinases - antagonists & inhibitors (7) 7
purification (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Communications, ISSN 2041-1723, 2012, Volume 3, Issue 1, p. 705
Journal Article
Journal of Tokyo Medical University, ISSN 0040-8905, 07/2014, Volume 72, Issue 3, pp. 243 - 244
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 03/2009, Volume 131, Issue 8, pp. 2766 - 2767
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 1063 - 11
We report the fabrication of flower-like CuO nanostructured surfaces via submerged photo-synthesis of crystallites (SPSC), which requires only UV illumination... 
THIN-FILMS | MECHANISM | MULTIDISCIPLINARY SCIENCES | GROWTH | NANOBELTS | NANOSTRUCTURES | FABRICATION | H-2 | PHOTOCATALYSTS | NANOWIRES | WATER | Antimicrobial agents | Bacteria | Antibacterial activity | Antimicrobial activity | α Radiation | Crystals | Index Medicus
Journal Article
Annals of Hematology, ISSN 0939-5555, 03/2019, Volume 98, Issue 3, pp. 723 - 733
Multiple myeloma (MM) is a uniformly fatal disorder of B cells characterized by the accumulation of abnormal plasma cells. Phosphoinositide 3-kinase (PI3K)... 
Feeder cell | PI3K | p110δ | Proteasome inhibitor | Multiple myeloma | p110 | HEMATOLOGY | LINES | PI3K INHIBITOR | B cells | Endothelial growth factors | Drug resistance | Sugars | Monosaccharides | Kinases | Apoptosis | Index Medicus
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 09/2019, pp. 1 - 3
Journal Article
International Journal of Hematology, ISSN 0925-5710, 8/2018, Volume 108, Issue 2, pp. 218 - 227
Journal Article
Cancer Science, ISSN 1347-9032, 05/2009, Volume 100, Issue 5, pp. 970 - 977
Journal Article
Experimental Hematology, ISSN 0301-472X, 09/2017, Volume 53, pp. S73 - S73
Journal Article
Oncotarget, ISSN 1949-2553, 08/2018, Volume 9, Issue 65, pp. 32496 - 32506
Abelson murine leukemia viral oncogene homolog (ABL) tyrosine kinase inhibitors (TKIs) have been shown to be effective for treatment of chronic myeloid... 
T315I mutation | Aurora kinase | Chronic myeloid leukemia | ABL tyrosine kinase inhibitor | Cell cycle
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 2668 - 12
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e89080
Resistance to imatinib (Gleevec(R)) in cancer cells is frequently because of acquired point mutations in the kinase domain of BCR-ABL. Ponatinib, also known as... 
CHRONIC MYELOGENOUS LEUKEMIA | DEPSIPEPTIDE | CELLS | MULTIDISCIPLINARY SCIENCES | RESISTANT LEUKEMIA | STAT5 | CANCER | FK228 | CHRONIC MYELOID-LEUKEMIA | HDAC | Apoptosis - drug effects | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Fusion Proteins, bcr-abl - genetics | Animals | Mice, Nude | Protein Kinase Inhibitors - therapeutic use | K562 Cells | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Hydroxamic Acids - therapeutic use | Cell Proliferation - drug effects | Histone Deacetylase Inhibitors - therapeutic use | Mice | Imidazoles - therapeutic use | Mutation | Fusion Proteins, bcr-abl - metabolism | Pyridazines - therapeutic use | Care and treatment | Gene mutations | Analysis | Leukemia | Genetic aspects | Drug therapy | Cancer | BCR protein | Drugs | Histone deacetylase | Cell culture | Phosphorylation | Laboratories | Toxicity | Cytotoxicity | Intracellular signalling | Kinases | ADP | Caspase-3 | Proteins | Cell growth | Ribose | Inhibition | Fusion protein | Protein-tyrosine kinase | Chromosomes | Deoxyribonucleic acid--DNA | Tyrosine | Imatinib | Immunoglobulins | Hematology | Internal medicine | Therapeutic applications | Hydroxamic acid | Poly(ADP-ribose) polymerase | Caspase | Abl protein | Gene expression | Medicine | Polymerase | Inhibitors | Cell lines | Stem cells | Combined treatment | Binding sites | Apoptosis | Deoxyribonucleic acid | DNA
Journal Article